Wave Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WVE and other ETFs, options, and stocks.

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. 

CEO
Paul B. Bolno
CEOPaul B. Bolno
Employees
288
Employees288
Headquarters
Singapore, Central Singapore
HeadquartersSingapore, Central Singapore
Founded
2012
Founded2012
Employees
288
Employees288

WVE Key Statistics

Market cap
3.34B
Market cap3.34B
Price-Earnings ratio
-24.78
Price-Earnings ratio-24.78
Dividend yield
Dividend yield
Average volume
16.67M
Average volume16.67M
High today
$20.97
High today$20.97
Low today
$18.80
Low today$18.80
Open price
$19.93
Open price$19.93
Volume
4.97M
Volume4.97M
52 Week high
$20.97
52 Week high$20.97
52 Week low
$5.28
52 Week low$5.28

Stock Snapshot

Wave Life Sciences(WVE) stock is priced at $20.00, giving the company a market capitalization of 3.34B. It carries a P/E multiple of -24.78.

During the trading session on 2025-12-09, Wave Life Sciences(WVE) shares reached a daily high of $20.97 and a low of $18.80. At a current price of $20.00, the stock is +6.4% higher than the low and still -4.6% under the high.

Trading activity shows a volume of 4.97M, compared to an average daily volume of 16.67M.

The stock's 52-week range extends from a low of $5.28 to a high of $20.97.

The stock's 52-week range extends from a low of $5.28 to a high of $20.97.

WVE News

TipRanks 15h
Wave Life Sciences upgraded to Outperform at RBC on rapid WVE-007 effect

As previously reported, RBC Capital analyst Luca Issi upgraded Wave Life Sciences (WVE) to Outperform from Sector Perform with a price target of $27, up from $9...

The Motley Fool 15h
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday

We have an emerging new entrant in the increasingly crowded weight loss drug space. Even in the volatile biotech sector, it's rare for a company's stock price...

Why Wave Life Sciences Stock Vaulted 146% Higher on Monday
TipRanks 1d
Wave Life Sciences Announces Positive Phase 1 Trial Results

TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...

Analyst ratings

100%

of 16 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own WVE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.